ABCG2 and lung adenocarcinoma: To examine this, PLK1 expression was depleted using two PLK1 shRNA with different target sequences showing efficient downregulation of PLK1 [23] to observe whether ABC transporters can be downregulated in paclitaxel-resistant lung adenocarcinoma cells (Figure 1C,D).